Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial

BACKGROUND: This randomized phase III study was to evaluate the efficacy and safety of cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of peritoneal carcinomatosis (PC) from gastric cancer. METHODS: Sixty-eight gastric PC patients were randomized...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Yang, Xiao-Jun, Huang, Chao-Qun, Suo, Tao, Mei, Lie-Jun, Yang, Guo-Liang, Cheng, Fu-Lin, Zhou, Yun-Feng, Xiong, Bin, Yonemura, Yutaka, Li, Yan
Format: Artigo
Idioma:Inglês
Publicat: Springer-Verlag 2011
Matèries:
Gastrointestinal Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3087875/
https://ncbi.nlm.nih.gov/pubmed/21431408
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-011-1631-5
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars